Drugs / TMZ
last change May 2016 re-read 9 days ago

TMZ

Developed for
glioma

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 2 NCT00727506 Comparator Jul 2008 → May 2011 glioma Boehringer Ingelheim Completed Missed primary

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TMZ ClinicalTrials.gov intervention name — accepted as the source's own label NCT00727506 ↗